Distinct molecular mechanisms contribute to the reduction of melanoma growth and tumor pain after systemic and local depletion of alpha‐Synuclein in mice

Alpha-synuclein in Parkinson’s disease and other synucleinopathies: from overt neurodegeneration back to early synaptic dysfunction

(2023) Paolo Calabresi et al.   Cell Death & Disease

Alpha synuclein, the culprit in Parkinson disease, is required for normal immune function

(2022) Md Masud Alam et al.   Cell Reports

The Role of AlphαSynuclein in Mouse Models of Acute, Inflammatory and Neuropathic Pain

(2022) Moritz Möller et al.   Cells

Knocking out alpha-synuclein in melanoma cells dysregulates cellular iron metabolism and suppresses tumor growth

(2021) Sahar Shekoohi et al.   Scientific Reports

Alpha-synuclein increases in rodent and human spinal cord injury and promotes inflammation and tissue loss

(2021) Andrew D. Sauerbeck et al.   Scientific Reports

Alpha-Synuclein Accumulation and Its Phosphorylation in the Enteric Nervous System of Patients Without Neurodegeneration: An Explorative Study

(2020) Lu-Lu Bu et al.   Frontiers in Aging Neuroscience

Gastrointestinal Immunity and Alpha-Synuclein

(2019) Denise Barbut et al.   Journal of Parkinsons Disease

Mechanism and medical implications of mammalian autophagy

(2018) Ivan Dikic et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Parkinson’s Disease and Melanoma: Co-Occurrence and Mechanisms

(2018) Anindita Bose et al.   Journal of Parkinsons Disease

A Role for Neuronal Alpha-Synuclein in Gastrointestinal Immunity

(2017) Ethan Stolzenberg et al.   Journal of Innate Immunity

Epidemiology of Parkinson’s disease

(2017) Ole-Bjørn Tysnes et al.   JOURNAL OF NEURAL TRANSMISSION

Targeted agents and immunotherapies: optimizing outcomes in melanoma

(2017) Jason J. Luke et al.   Nature Reviews Clinical Oncology

Non-motor features of Parkinson disease

(2017) Anthony H.V. Schapira et al.   NATURE REVIEWS NEUROSCIENCE

Treatment with diphenyl–pyrazole compound anle138b/c reveals that α-synuclein protects melanoma cells from autophagic cell death

(2017) Elisa Turriani et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Cell Biology and Pathophysiology of α-Synuclein

(2017) Jacqueline Burré et al.   Cold Spring Harbor Perspectives in Medicine

Autophagy enhancement is rendered ineffective in presence of α-synuclein in melanoma cells

(2017) Swapna Nandakumar et al.   Journal of Cell Communication and Signaling

The nonmotor features of Parkinsonʼs disease

(2016) Heinz Reichmann et al.   CURRENT OPINION IN NEUROLOGY

Alpha-Synuclein Expression Restricts RNA Viral Infections in the Brain

(2015) Erica L. Beatman et al.   JOURNAL OF VIROLOGY

α-Synuclein, a chemoattractant, directs microglial migration via H2O2-dependent Lyn phosphorylation

(2015) Shijun Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Atg7 Overcomes Senescence and Promotes Growth of BrafV600E-Driven Melanoma

(2015) X. Xie et al.   Cancer Discovery

Emerging analgesic drugs for Parkinson's disease

(2012) Santiago Perez-Lloret et al.   EXPERT OPINION ON EMERGING DRUGS

Measurements of Tumor Cell Autophagy Predict Invasiveness, Resistance to Chemotherapy, and Survival in Melanoma

(2011) X.-H. Ma et al.   CLINICAL CANCER RESEARCH

Autophagy in tumorigenesis and energy metabolism: friend by day, foe by night

(2011) Robin Mathew et al.   CURRENT OPINION IN GENETICS & DEVELOPMENT

The association between Parkinson's disease and melanoma

(2011) Tianhong Pan et al.   INTERNATIONAL JOURNAL OF CANCER

The Protein Kinase IKK  Is a Potential Target for the Treatment of Inflammatory Hyperalgesia

(2011) C. V. Moser et al.   JOURNAL OF IMMUNOLOGY

Distinct Roles In Vivo for the Ubiquitin-Proteasome System and the Autophagy-Lysosomal Pathway in the Degradation of  -Synuclein

(2011) D. Ebrahimi-Fakhari et al.   JOURNAL OF NEUROSCIENCE

α-Synuclein Expression Selectively Affects Tumorigenesis in Mice Modeling Parkinson's Disease

(2011) Eitan Israeli et al.   PLoS One

The regulatory role of α-synuclein and parkin in neuronal cell apoptosis; possible implications for the pathogenesis of Parkinson’s disease

(2010) Toru Yasuda et al.   APOPTOSIS

Pain is common in Parkinson's disease

(2010) Hasmet A. Hanagasi et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

α-Synuclein impairs macroautophagy: implications for Parkinson’s disease

(2010) Ashley R. Winslow et al.   JOURNAL OF CELL BIOLOGY

Parkinson's Disease-Related Protein, α-Synuclein, in Malignant Melanoma

(2010) Yasuhiro Matsuo et al.   PLoS One

   -Synuclein triple knockout mice reveal age-dependent neuronal dysfunction

(2010) B. Greten-Harrison et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions

(2009) Clelia Miracco et al.   HUMAN PATHOLOGY

Autophagy in cutaneous malignant melanoma

(2009) Rossitza Lazova et al.   JOURNAL OF CUTANEOUS PATHOLOGY

BrafV600E cooperates with Pten loss to induce metastatic melanoma

(2009) David Dankort et al.   NATURE GENETICS

The role of autophagy-lysosome pathway in neurodegeneration associated with Parkinson's disease

(2008) T. Pan et al.   BRAIN

Parkinson's disease: clinical features and diagnosis

(2008) J Jankovic   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Autophagy fights disease through cellular self-digestion

(2008) Noboru Mizushima et al.   NATURE

Pain in Parkinson’s disease: Prevalence and characteristics

(2008) A. G. Beiske et al.   PAIN